New York Times, April 9, 2010

The Food and Drug Administration announced that it was taking steps to reduce overdoses, underdoses, and other errors in radiation therapy by strengthening the agency's approval process for new radiotherapy equipment. In a letter to manufacturers, the F.D.A. said its action was based on a recent analysis of more than 1,000 reports of errors involving these devices that were filed over the last 10 years, the New York Times reports.

Facebook icon
LinkedIn icon
Twitter icon